Lanreotide acetate

SKU: orb1299003

Description

Lanreotide acetate is a synthetic somatostatin analog employed in research for its antineoplastic properties. It is widely used in studies of neuroendocrine tumors, such as carcinoid syndrome, to investigate receptor-mediated inhibition of hormone secretion and cell proliferation in both in vitro and in vivo models.

Research Area

Pharmacology & Drug Discovery

Key Properties

• Target: Somatostatin,Others
• CAS Number: 2378114-72-6
• MW: 1156.39
• Purity: 99.85% (May vary between batches)
• Formula: C₅₆H₇₃N₁₁O₁₂S₂
• SMILES: CC(O)=O.[H][C@@]1(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@H](N)Cc1ccc2ccccc2c1

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

108736-35-2, 108736-35-2 free base, adenoma, BIM23014, BIM-23014, BIM23014 Acetate, BIM-23014 Acetate, BIM 23014, BIM 23014 (acetate), BIM 23014 acetate, BIM 23014 Acetate, apoptosis, Inhibitor, Lanreotide, Lanreotide acetate, Lanreotide Acetate, Lanreotide acetate (108736-35-2 free base), hormone, GH-secreting, GH3 cells, inhibit, tumor, pituitary

Compound Identifiers

PubChem CID

6918010